Literature DB >> 1390186

Pigmented lesions as a sign of photodamage.

E Hölzle1.   

Abstract

Chronic exposure to ultraviolet (UV) radiation causes skin changes, known as photodamage. Apart from damage to the connective tissue of the dermis and to keratinocytes, pigmented lesions, known as 'age spots', occur. There are several types, but the most common lesions are the senile lentigines. The main differential diagnoses include reticular seborrhoeic keratosis and lentigo maligna, and histopathological examination is required for exact differentiation. Variants of lentigo senilis with acute onset after intense UV radiation are sunburn freckles. Psoralens- and UVA-induced freckles, and lentigines occur after phototherapy with artificial UV sources or use of sunbeds for cosmetic tanning. Ephelids are common genetically determined pigment spots appearing during childhood in a distinct photodistribution. Exposure to UV radiation also seems to play a role in the manifestation of acquired nevi. Since pigmented lesions in sun-damaged skin represent more than one entity, they differ in their response to treatment. This should be taken into account when the efficacy of topical therapy is evaluated.

Entities:  

Mesh:

Year:  1992        PMID: 1390186     DOI: 10.1111/j.1365-2133.1992.tb16989.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  10 in total

Review 1.  Elderly and sun-affected skin. Distinguishing between changes caused by aging and changes caused by habitual exposure to sun.

Authors:  R Jackson
Journal:  Can Fam Physician       Date:  2001-06       Impact factor: 3.275

2.  A split-face, evaluator-blind randomized study on the early effects of Q-switched Nd:YAG laser plus Er:YAG micropeel (combined therapy) versus Q-switched Nd:YAG alone in light solar lentigines in Asians.

Authors:  Hee Jin Jun; Sang Hyun Cho; Jeong Deuk Lee; Hei Sung Kim
Journal:  Lasers Med Sci       Date:  2013-11-29       Impact factor: 3.161

3.  Novel Low Fluence Combination Laser Treatment of Solar Lentigines in Type III Asian Skin.

Authors:  Brian Wei Cheng Anthony Tian
Journal:  J Cutan Aesthet Surg       Date:  2015 Oct-Dec

4.  The association between Solar Lentigines and Type-2 Diabetes.

Authors:  Bobak Moazzami; Niloofar Razavi; Mansour Babaei; Motahareh Haghparast; Mohammad Ali Bayani
Journal:  Caspian J Intern Med       Date:  2017

5.  Oral administration of French maritime pine bark extract (Flavangenol(®)) improves clinical symptoms in photoaged facial skin.

Authors:  Minao Furumura; Noriko Sato; Nobutaka Kusaba; Kinya Takagaki; Juichiro Nakayama
Journal:  Clin Interv Aging       Date:  2012-07-27       Impact factor: 4.458

6.  Extrinsic aging: UV-mediated skin carcinogenesis.

Authors:  Fragkiski Tsatsou; Myrto Trakatelli; Aikaterini Patsatsi; Konstantinos Kalokasidis; Dimitrios Sotiriadis
Journal:  Dermatoendocrinol       Date:  2012-07-01

7.  Accuracy of the first step of the dermatoscopic 2-step algorithm for pigmented skin lesions.

Authors:  Philipp Tschandl; Cliff Rosendahl; Harald Kittler
Journal:  Dermatol Pract Concept       Date:  2012-07-31

8.  Key regulatory role of dermal fibroblasts in pigmentation as demonstrated using a reconstructed skin model: impact of photo-aging.

Authors:  Christine Duval; Catherine Cohen; Corinne Chagnoleau; Virginie Flouret; Emilie Bourreau; Françoise Bernerd
Journal:  PLoS One       Date:  2014-12-09       Impact factor: 3.240

9.  Cooperation of endothelin-1 signaling with melanosomes plays a role in developing and/or maintaining human skin hyperpigmentation.

Authors:  Daiki Murase; Akira Hachiya; Mamiko Kikuchi-Onoe; Rachel Fullenkamp; Atsushi Ohuchi; Takashi Kitahara; Shigeru Moriwaki; Tadashi Hase; Yoshinori Takema
Journal:  Biol Open       Date:  2015-09-04       Impact factor: 2.422

10.  Skin Hyperpigmentation in Indian Population: Insights and Best Practice.

Authors:  Stephanie Nouveau; Divya Agrawal; Malavika Kohli; Francoise Bernerd; Namita Misra; Chitra Shivanand Nayak
Journal:  Indian J Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.494

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.